TissueGnostics
Private Company
Funding information not available
Overview
TissueGnostics is a privately held, revenue-generating company founded in 2003 (with a 2008 incorporation reference) that provides a comprehensive platform for automated microscopy and quantitative tissue image analysis. Its core offerings include the modular TissueFAXS imaging systems and the powerful StrataQuest analysis software, which are widely adopted in academic and clinical research for spatial biology and digital pathology applications. The company leverages AI/ML tools and a library of predefined workflows (AppCenter) to help researchers derive publication-ready data from complex tissue samples. With a strong focus on customer support and strategic partnerships, TissueGnostics is positioned in the growing markets of digital pathology and spatial omics.
Technology Platform
Integrated hardware (TissueFAXS whole-slide imaging systems) and software (StrataQuest image analysis platform) for automated, quantitative tissue and cell analysis. The platform includes spectral imaging, AI/ML-based cell classification, spatial analysis tools, and a library of predefined workflows (AppCenter).
Funding History
1Opportunities
Risk Factors
Competitive Landscape
TissueGnostics competes in a crowded field with major players like Roche (Ventana), Philips, and Leica Biosystems in digital pathology, and software specialists like Indica Labs, Visiopharm, and Akoya Biosciences in image analysis. Its differentiation lies in its integrated hardware-software platform, focus on high-flexibility and custom analysis for complex research questions, and strong academic reputation.